Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
Merlotti A, Alterio D, Orlandi E, Racadot S, Bonomo P, Franco P, D'Angelo E, Ursino S, Pointreau Y, Lapeyre M, Graff P, Di Rito A, Argenone A, Musio D, De Felice F, Dionisi F, Fanetti G, D'Onofrio I, Belgioia L, Maddalo M, Scricciolo M, Bourhis J, Russi E, Thariat J. Merlotti A, et al. Among authors: bourhis j. Radiother Oncol. 2022 Dec;177:95-104. doi: 10.1016/j.radonc.2022.10.035. Epub 2022 Nov 3. Radiother Oncol. 2022. PMID: 36336113 Review.
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, Maingon P, Giraud P, Bourhis J, Marchesi V, Mège A, Peiffert D. Graff P, et al. Among authors: bourhis j. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1309-17. doi: 10.1016/j.ijrobp.2006.11.012. Epub 2007 Feb 7. Int J Radiat Oncol Biol Phys. 2007. PMID: 17289292
Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.
Ortholan C, Lusinchi A, Italiano A, Bensadoun RJ, Auperin A, Poissonnet G, Bozec A, Arriagada R, Temam S, Benezery K, Thariat J, Tao Y, Janot F, Mamelle G, Vallicioni J, Follana P, Peyrade F, Sudaka A, Bourhis J, Dassonville O. Ortholan C, et al. Among authors: bourhis j. Radiother Oncol. 2009 Dec;93(3):516-23. doi: 10.1016/j.radonc.2009.07.015. Epub 2009 Aug 21. Radiother Oncol. 2009. PMID: 19699545
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.
Tortochaux J, Tao Y, Tournay E, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P, Maingon P, Calais G, Daly-Schveitzer N, Verrelle P, Bourhis J. Tortochaux J, et al. Among authors: bourhis j. Radiother Oncol. 2011 Jul;100(1):70-5. doi: 10.1016/j.radonc.2011.06.025. Epub 2011 Jul 7. Radiother Oncol. 2011. PMID: 21741720 Clinical Trial.
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
Bourhis J, Lapeyre M, Tortochaux J, Lusinchi A, Etessami A, Ducourtieux M, Geoffrois L, Domenge C, Verrelle P, Wibault P, Janot F, Temam S, Blanchard P, Tao YG, Auperin A. Bourhis J, et al. Radiother Oncol. 2011 Jul;100(1):56-61. doi: 10.1016/j.radonc.2011.07.006. Epub 2011 Aug 8. Radiother Oncol. 2011. PMID: 21831465 Clinical Trial.
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, Gery B, Martin L, Alfonsi M, Desprez P, Pignon T, Bardet E, Rives M, Geoffrois L, Daly-Schveitzer N, Sen S, Tuchais C, Dupuis O, Guerif S, Lapeyre M, Favrel V, Hamoir M, Lusinchi A, Temam S, Pinna A, Tao YG, Blanchard P, Aupérin A. Bourhis J, et al. Lancet Oncol. 2012 Feb;13(2):145-53. doi: 10.1016/S1470-2045(11)70346-1. Epub 2012 Jan 18. Lancet Oncol. 2012. PMID: 22261362 Clinical Trial.
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.
Brouwer CL, Steenbakkers RJ, Bourhis J, Budach W, Grau C, Grégoire V, van Herk M, Lee A, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Rosenthal DI, Sijtsema NM, Langendijk JA. Brouwer CL, et al. Among authors: bourhis j. Radiother Oncol. 2015 Oct;117(1):83-90. doi: 10.1016/j.radonc.2015.07.041. Epub 2015 Aug 13. Radiother Oncol. 2015. PMID: 26277855
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N, Ozsahin M, Zeverino M, Belmondo B, Durham AD, Lovis A, Simons J, Long O, Duclos F, Prior J, Denys A, Beigelman C, Sozzi WJ, Grant K, Gautier-Dechaud V, Peters S, Vienne M, Moeckli R, Bourhis J. Péguret N, et al. Among authors: bourhis j. Radiother Oncol. 2016 Feb;118(2):220-6. doi: 10.1016/j.radonc.2015.10.011. Radiother Oncol. 2016. PMID: 26979264
733 results